Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature

  title={Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature},
  author={Nadine N Hauer and Heinrich Sticht and Sangamitra Boppudi and Christian B{\"u}ttner and Christine Kraus and Udo Trautmann and Martin Zenker and Christiane Zweier and Antje Wiesener and Rami Abou Jamra and Dagmar Wieczorek and Jaqueline Kelkel and A Jung and Steffen Uebe and Arif B. Ekici and Tilman Robert Rohrer and Andr{\'e} Reis and H. G. D{\"o}rr and Christian T Thiel},
  booktitle={Scientific Reports},
Short stature is a common pediatric disorder affecting 3% of the population. However, the clinical variability and genetic heterogeneity prevents the identification of the underlying cause in about 80% of the patients. Recently, heterozygous mutations in the ACAN gene coding for the proteoglycan aggrecan, a main component of the cartilage matrix, were associated with idiopathic short stature. To ascertain the prevalence of ACAN mutations and broaden the phenotypic spectrum in patients with… CONTINUE READING

Similar Papers

Figures, Tables, and Topics from this paper.


Publications referenced by this paper.

Identification of a novel heterozygous mutation of the Aggrecan gene in a family with idiopathic short stature and multiple intervertebral disc herniation

S Dateki
  • J Hum Genet
  • 2017

Novel pathogenic ACAN variants in non-syndromic short stature patients.

  • Clinica chimica acta; international journal of clinical chemistry
  • 2017

Analysis of protein‐coding genetic variation in 60,706 humans

M Lek
  • bioRxiv
  • 2016

Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations

A Gkourogianni
  • J Clin Endocrinol Metab,
  • 2016

A general framework for estimating the relative pathogenicity of human genetic variants

M Kircher
  • Nat Genet
  • 2014